Updated efficacy and safety of CDK4/6 inhibitors plus endocrine therapy in elderly women with HR+/HER-2 metastatic or advanced breast cancer: patient-level network meta-analysis
Aging · 2025
DOI: 10.18632/aging.206257 ↗Kurz gefasst
Netzwerk-Metaanalyse in der Zeitschrift Aging, 2025. Verfasst von Henry Wc Leung und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, An-Nan Hospital, China Medical University, Tainan, Taiwan. Hauptthemen laut MEDLINE: Antineoplastic Agents, Hormonal, Antineoplastic Combined Chemotherapy Protocols, Breast Neoplasms, Cyclin-Dependent Kinase 4. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, An-Nan Hospital, China Medical University, Tainan, Taiwan.
- Department of Medical Materials Supply, Tainan Municipal Hospital (Managed by Show Chwan Medical Care Corporation), Tainan, Taiwan.
- Department of Radiology, An-Nan Hospital, China Medical University, Tainan, Taiwan.
- Department of Pharmacy, Kaohsiung Show Chwan Memorial Hospital, Kaohsiung, Taiwan.
Zitieren
APA
Leung, H. W., Tsai, M. C., Leung, S. H., Wang, S. Y., & Chan, A. L. (2025). Updated efficacy and safety of CDK4/6 inhibitors plus endocrine therapy in elderly women with HR+/HER-2 metastatic or advanced breast cancer: patient-level network meta-analysis. Aging. https://doi.org/10.18632/aging.206257
Vancouver
Leung HW, Tsai MC, Leung SH, Wang SY, Chan AL. Updated efficacy and safety of CDK4/6 inhibitors plus endocrine therapy in elderly women with HR+/HER-2 metastatic or advanced breast cancer: patient-level network meta-analysis. Aging. 2025. doi:10.18632/aging.206257
BibTeX
@article{Leung2025,
author = {Leung, Henry Wc and Tsai, Mei-Ching and Leung, Shin-Hang and Wang, Shyh-Yau and Chan, Agnes Lf},
title = {Updated efficacy and safety of CDK4/6 inhibitors plus endocrine therapy in elderly women with HR+/HER-2 metastatic or advanced breast cancer: patient-level network meta-analysis},
journal = {Aging},
year = {2025},
doi = {10.18632/aging.206257}
}
EUVIMED